Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Rivian Automotive, Inc. (RIVN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Rivian Automotive, Inc. — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.66 (market cap $3.94B), while Rivian Automotive, Inc. trades at $12.9 (market cap $19.36B). The key difference: Rivian Automotive, Inc. is far larger — about 4.9× Edgewise Therapeutics Inc. Common Stock's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Rivian Automotive, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Rivian Automotive, Inc. for 61 Days on average.
| EWTX | RIVN | |
|---|---|---|
Market Cap | $3.94B | $19.36B |
Volume | 810,104 | 16,483,640 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.35 | $22.45 |
52-Week Low | $14.89 | $12.50 |
Typical Hold Time | 0 Days | 61 Days |
Enterprise Value | $3.48B | $19.40B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Rivian Automotive (RIVN) trades at $12.95, down 4.36% amid a bearish technical signal despite beating Q3 2026 delivery estimates with 19,248 vehicles. The company maintains negative profitability with a net income margin of -54.95% but shows improving revenue trends, reaching $5.39 billion in 2025. Cash flow remains negative, though operational losses have narrowed significantly from previous years.
The stock presents a high-risk opportunity with Wall Street consensus leaning bullish (48% buy ratings) and a $16.89 price target, implying potential upside. Key risks include persistent cash burn, intense EV competition, and execution challenges in scaling R2 production and autonomy technology, which are critical for achieving profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Rivian Automotive, Inc.
Rivian Automotive, Inc. is an automotive technology company. The Company designs and manufactures vans, trucks, and sports utility vehicles, as well as offers repair and maintenance services. Rivian Automotive serves customers in North America and the United Kingdom.
Read more on RIVN →
